These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Molecular pathology, developmental changes and synaptic dysfunction in (pre-) symptomatic human C9ORF72-ALS/FTD cerebral organoids. van der Geest AT; Jakobs CE; Ljubikj T; Huffels CFM; Cañizares Luna M; Vieira de Sá R; Adolfs Y; de Wit M; Rutten DH; Kaal M; Zwartkruis MM; Carcolé M; Groen EJN; Hol EM; Basak O; Isaacs AM; Westeneng HJ; van den Berg LH; Veldink JH; Schlegel DK; Pasterkamp RJ Acta Neuropathol Commun; 2024 Sep; 12(1):152. PubMed ID: 39289761 [TBL] [Abstract][Full Text] [Related]
4. Frontotemporal dementia due to C9ORF72 mutations: clinical and imaging features. Sha SJ; Takada LT; Rankin KP; Yokoyama JS; Rutherford NJ; Fong JC; Khan B; Karydas A; Baker MC; DeJesus-Hernandez M; Pribadi M; Coppola G; Geschwind DH; Rademakers R; Lee SE; Seeley W; Miller BL; Boxer AL Neurology; 2012 Sep; 79(10):1002-11. PubMed ID: 22875087 [TBL] [Abstract][Full Text] [Related]
5. Thalamic nuclei in frontotemporal dementia: Mediodorsal nucleus involvement is universal but pulvinar atrophy is unique to C9orf72. Bocchetta M; Iglesias JE; Neason M; Cash DM; Warren JD; Rohrer JD Hum Brain Mapp; 2020 Mar; 41(4):1006-1016. PubMed ID: 31696638 [TBL] [Abstract][Full Text] [Related]
6. Basal parasympathetic deficits in C9orf72 hexanucleotide repeat expansion carriers relate to smaller frontoinsula and thalamus volume and lower empathy. R K Roy A; Noohi F; Morris NA; Ljubenkov P; Heuer H; Fong J; Hall M; Lario Lago A; Rankin KP; Miller BL; Boxer AL; Rosen HJ; Seeley WW; Perry DC; Yokoyama JS; Lee SE; Sturm VE Neuroimage Clin; 2024; 43():103649. PubMed ID: 39098187 [TBL] [Abstract][Full Text] [Related]
7. A C9ORF72 BAC mouse model recapitulates key epigenetic perturbations of ALS/FTD. Esanov R; Cabrera GT; Andrade NS; Gendron TF; Brown RH; Benatar M; Wahlestedt C; Mueller C; Zeier Z Mol Neurodegener; 2017 Jun; 12(1):46. PubMed ID: 28606110 [TBL] [Abstract][Full Text] [Related]
8. Stable transgenic C9orf72 zebrafish model key aspects of the ALS/FTD phenotype and reveal novel pathological features. Shaw MP; Higginbottom A; McGown A; Castelli LM; James E; Hautbergue GM; Shaw PJ; Ramesh TM Acta Neuropathol Commun; 2018 Nov; 6(1):125. PubMed ID: 30454072 [TBL] [Abstract][Full Text] [Related]
9. Nuclear lamina invaginations are not a pathological feature of C9orf72 ALS/FTD. Coyne AN; Rothstein JD Acta Neuropathol Commun; 2021 Mar; 9(1):45. PubMed ID: 33741069 [TBL] [Abstract][Full Text] [Related]
10. C9orf72 ALS-FTD: recent evidence for dysregulation of the autophagy-lysosome pathway at multiple levels. Beckers J; Tharkeshwar AK; Van Damme P Autophagy; 2021 Nov; 17(11):3306-3322. PubMed ID: 33632058 [TBL] [Abstract][Full Text] [Related]
11. Different CSF protein profiles in amyotrophic lateral sclerosis and frontotemporal dementia with Barschke P; Oeckl P; Steinacker P; Al Shweiki MR; Weishaupt JH; Landwehrmeyer GB; Anderl-Straub S; Weydt P; Diehl-Schmid J; Danek A; Kornhuber J; Schroeter ML; Prudlo J; Jahn H; Fassbender K; Lauer M; van der Ende EL; van Swieten JC; Volk AE; Ludolph AC; Otto M; J Neurol Neurosurg Psychiatry; 2020 May; 91(5):503-511. PubMed ID: 32132225 [TBL] [Abstract][Full Text] [Related]
12. Targeted next-generation sequencing study in familial ALS-FTD Portuguese patients negative for C9orf72 HRE. Gromicho M; Coutinho AM; Pronto-Laborinho AC; Raposeiro R; Tavares J; Antunes D; de Carvalho M J Neurol; 2020 Dec; 267(12):3578-3592. PubMed ID: 32638105 [TBL] [Abstract][Full Text] [Related]
13. [Impact of C9orf72 on Japanese Patients with Amytrophic Lateral Sclerosis (ALS)/Frontotemporal Dementia (FTD)]. Tomiyama H Brain Nerve; 2019 Nov; 71(11):1190-1208. PubMed ID: 31722305 [TBL] [Abstract][Full Text] [Related]
14. Inflammasome-Mediated Neuronal-Microglial Crosstalk: a Therapeutic Substrate for the Familial C9orf72 Variant of Frontotemporal Dementia/Amyotrophic Lateral Sclerosis. Trageser KJ; Yang EJ; Smith C; Iban-Arias R; Oguchi T; Sebastian-Valverde M; Iqbal UH; Wu H; Estill M; Al Rahim M; Raval U; Herman FJ; Zhang YJ; Petrucelli L; Pasinetti GM Mol Neurobiol; 2023 Jul; 60(7):4004-4016. PubMed ID: 37010807 [TBL] [Abstract][Full Text] [Related]
15. Investigating the Genetic Profile of the Amyotrophic Lateral Sclerosis/Frontotemporal Dementia (ALS-FTD) Continuum in Patients of Diverse Race, Ethnicity and Ancestry. Mesaros M; Lenz S; Lim W; Brown J; Drury L; Roggenbuck J Genes (Basel); 2021 Dec; 13(1):. PubMed ID: 35052416 [TBL] [Abstract][Full Text] [Related]
16. Network degeneration and dysfunction in presymptomatic Lee SE; Sias AC; Mandelli ML; Brown JA; Brown AB; Khazenzon AM; Vidovszky AA; Zanto TP; Karydas AM; Pribadi M; Dokuru D; Coppola G; Geschwind DH; Rademakers R; Gorno-Tempini ML; Rosen HJ; Miller BL; Seeley WW Neuroimage Clin; 2017; 14():286-297. PubMed ID: 28337409 [TBL] [Abstract][Full Text] [Related]
17. Understanding the relationship between cerebellum and the frontal-cortex region of C9orf72-related amyotrophic lateral sclerosis: A comparative analysis of genetic features. Prasad K; Hassan MI; Raghuvanshi S; Kumar V PLoS One; 2024; 19(5):e0301267. PubMed ID: 38753768 [TBL] [Abstract][Full Text] [Related]
18. Thalamic atrophy in frontotemporal dementia - Not just a Bocchetta M; Gordon E; Cardoso MJ; Modat M; Ourselin S; Warren JD; Rohrer JD Neuroimage Clin; 2018; 18():675-681. PubMed ID: 29876259 [TBL] [Abstract][Full Text] [Related]
19. G-Quadruplexes Formation by the Zhang Y; Huang J; Yu K; Cui X Molecules; 2023 Jun; 28(12):. PubMed ID: 37375224 [TBL] [Abstract][Full Text] [Related]